Only 14% of adults across the U.S. have received the updated COVID-19 vaccine, a number way too low, Dr. Mandy Cohen, director of the Centers for Disease Control and Prevention and a Baldwin native, said during a visit to Long Island on Monday.
Cohen urged local residents to get the vaccine, noting that while casesappear to be low, almost 1,000 New Yorkers died from COVID-19 over the last three months. She echoed the vaccination call for flu and RSV,pointing out both are on the rise locally and nationally.
Im here in Nassau County where I grew up, said Cohen, after a tour of Nassau University Medical Center in East Meadow. I wouldn't recommend something I wouldn't recommend for my own parents for my own daughters. We all got the updated COVID vaccine, the updated flu shot. So I hope folks in Nassau County can hear from one of their own. I'm here back at home to say protect yourself this holiday season.
Statistics from the state Department of Health show about 7.2% of Nassau County residents and 6.8% of Suffolk County residents have received the updated vaccine, although those numbers may be incomplete because reporting is no longer mandatory.The statewide percentage, in areas outside of New York City, is8.7%.
The national percentage cant be directly compared with county and state numbers, however, since theyre collected by different methods.
The CDC numbers are based on a national survey, which is self-reported. As of Nov.17, 5.4% of children, 14.8% of adults over the age of 18 and 31.7% of adults 65 years of age and older had received the updated COVID-19 vaccine.
This is the first year vaccines for RSV, or respiratory syncytial virus,are available, targeted for young children, pregnant women and older adults. Cohen acknowledgedthe RSV monoclonal antibodies treatment for infants and young children is still in short supply.
The manufacturer did not anticipate the high demand for this shot, Cohen said. I personally have been on the phone with them dozens of times to try to speed up production. We actually just released another 70,000 doses.
Cohen said people should be mindful as they gather and travel for Thanksgiving, because those events can lead to the spread of viruses.
I know it's hard to miss family gatherings, but if you're sick, please don't spread those viruses around, she said. We want folks to stay home if they're sick, get tested, get treatment, and make sure to do the things we've learned these last few years: Wash your hands, use masks, open that window. There's plenty of ways to stay safe.
Earlier in the morning, Cohen received a citation from Nassau County Executive Bruce Blakeman during a ceremony at his office. She was accompanied by her mother, Susan Krauthamer, a nurse practitioner who previously worked at Hempstead General Hospital and Mercy Medical Center.
Dr. John Zaso, a pediatrician in East Meadow affiliated with NUMC, said there has been an uptick in flu and RSV cases in recent weeks.
RSV and flu are keeping us busy right now, he said, noting most of the flu cases he sees are among children who were not vaccinated.
This year, the match is very good between 60 and 65%, he said of the flu vaccines effectiveness to strains that are circulating. Its never too late to get that. The risk of hospitalization is much less if you get that vaccine.
Lisa joined Newsday as a staff writer in 2019. She previously worked at amNewYork, the New York Daily News and the Asbury Park Press covering politics, government and general assignment.
Now is the time to get this years COVID-19 and flu vaccines
Vermont Business Magazine Fall and winter are the seasons when respiratory viruses spread more easily, and that means now is the best time to protect yourself and loved ones from serious illness and hospitalization. The Health Department is urging everyone 6 months and older to get this years COVID-19 and flu vaccines.
People can also talk to their doctor about new RSV (respiratory syncytial virus) immunization options for babies, people who are pregnant, and adults ages 60 and older.
Having vaccines available for three potentially dangerous illnesses can make a real impact on all our health, said Health Commissioner Mark Levine, MD. Its a busy time of year, people are arranging travel and holiday get-togethers, and no one wants to be sick. So, lets protect ourselves and prevent the spread of germs now and through the winter.
Vaccines protect against severe illness and hospitalization. If you do get sick, being vaccinated can make your symptoms milder and not as long-lasting. Dr. Levine said getting vaccinated is especially important for people at higher risk of getting very sick due to certain medical conditions or weakened immune systems.
With the end of the pandemic emergency, people will get their COVID-19 vaccinations in the same locations where they receive their other routine vaccinations, such as for the flu. Its also OK for people to get flu and COVID-19 vaccinations at the same time. These vaccines take up to two weeks to be fully effective.
Vaccinations are available by appointment at doctors offices, pharmacies, community health centers and clinics across the state. Adults ages 65 and older should contact their local pharmacies to schedule their COVID-19 vaccine appointments or check with their health care provider. Community and partner organizations are also offering clinics to help reach people who are homebound and others.
Health insurance will cover the cost for most people to get vaccinated. Adults without health insurance, or whose insurance does not include immunizations, can get COVID-19 vaccine at no cost through the Bridge Access Program. To find a participating location, visit Vaccines.gov or reach out to your Local Health Office.
Dr. Levine said more doses of COVID-19 vaccine continue coming into the state, and that everyone will be able to get vaccinated. The good news is that people want to get vaccinated, and I appreciate everyones patience as doses become available.
The Health Department has also launched a new dashboard that shows how many people have been vaccinated against COVID-19 and flu. As of November 14, 12% of people in Vermont have received their COVID-19 vaccine, and 24% have gotten their flu shot.
In addition to getting vaccinated, there are everyday things you can do to avoid germs and stay healthy:
The Vermont Health Department monitors COVID-19 activity and flu activity throughout the year. Flu activity in the state is currently minimal but is expected to increase in the coming weeks. The number of COVID-19 hospitalizations is also low but has risen slightly in recent weeks. Nationally, respiratory virus activity has been increasing.
You can find more information, including resources in multiple languages at HealthVermont.gov/MyVaccine.
About the Department of Health
We have been the state's public health agency for more than 130 years, working every day to protect and promote the health of Vermonters.
Source: 11.16.2023. BURLINGTON, VT Vermont Department of Health HealthVermont.gov
Dr Hilary Jones has revealed that the UK hasn't got any Covid-19 variants of concern, but warned that the flu is "more of a threat" this winter
Dr Hilary Jones has claimed that Brits should not be routine testing for Covid-19, as the flu "poses more of a threat" this winter.
The Good Morning Britain star said the UK "hasn't got any variants of concern" as the current strain is not causing a large number of hospitalisations. The latest GOV.UK data shows that there were 2,519 patients admitted to hospital in the seven days leading up to November 3.
According to the UK Health Security Agency (UKHSA), emergent variant BA.2.86 is no more likely to evade existing antibodies than XBB.1.5. It also notes that there is no evidence to suggest BA.2.86 is more likely to make people seriously ill than currently-circulating variants.
Speaking to the Mirror, Dr Hilary said: "I dont think we should be regularly testing. I think if youve got symptoms and youre not sure whether its a bad cold or Covid-19 then its worth testing because its very cheap to do that and its useful to know, not just for yourself but for other people.
"We know Covid-19 is around, we havent got any variants of concern particularly at the moment. We do have a different strain, but it doesnt seem to be more virulent than whats gone before and its not causing a large number of hospitalisations or deaths." He added: "We expected Covid-19 to cause a few more cases as winter approaches and for the same reasons were going to see more colds and flu. However, were living with Covid-19 now and actually flu probably poses more of a threat this winter than Covid-19."
The Lorraine presenter explained that after flu rates soared in the Southern Hemisphere, including Australia and Chile, the UK is likely to follow a similar pattern. According to the World Health Organisation (WHO), Southern Hemispheric countries experienced high or earlier flu activity compared to what was seen prior to the Covid-19 pandemic.
Last year, the flu virus was responsible for more than 14,000 excess deaths, and over 10,000 children were hospitalised. Dr Hilary is urging those eligible for free NHS booster of Covid-19 and the flu jab to make sure they book an appointment, especially people in vulnerable groups.
"Those eligible for free NHS booster of Covid-19 and the flu vaccine, I would really recommend that they get that done to give themselves really good protection against the worst of the circulating flu viruses," he said. Pregnant women and those with ongoing health conditions are among those who are eligible for the free flu jab, but the UKHSA warns that these groups have more recently had lower vaccine uptake despite being at higher risk.
Dr Hilary highlights how most people wont get more than one or two episodes of the flu in their lifetime and that the virus "is very different" to a bad cold. "With real flu youre likely to have a very high temperature, youre going to have a headache, a hacking cough, a very sore throat, enlarged glands in your neck. Youre going to feel awful and you wont be able to get out of bed, even if you want to," he said.
The expert explained that people will not experience a high temperature with Covid-19 or a cold. Its common for people with Covid-19 or the flu to suffer from aching muscles and joints, however Dr Hilary describes Covid-19 symptoms as "nebulous". He said: "We used to talk about a dry persistent cough, fatigue, nasal congestion, but actually there are many more symptoms that people can have with Covid-19, or no symptoms at all.
"But some people get aching muscles and joints, some people have overwhelming fatigue, some people get a headache, and some people get digestive symptoms. Covid-19 is really a strange virus in that it can affect people in different ways. If youre in doubt just do a test, the Covid-19 lateral flow test is still widely available and its still accurate."
With a common cold, the health guru suggests common symptoms include "nasal congestion, runny nose, red eyes, sneezing, bit of a sore throat, no temperature usually, and slightly sore glands." Dr Hilary, who is representing Manuka Doctor, recommends treating cold symptoms with Manuka honey, which boasts antibacterial properties.
These can help to relieve underlying symptoms for colds and coughs as Manuka honey contains methylglyoxal (MGO). Symptomatic relief from colds can also be achieved by drinking plenty of fluids and taking paracetamol or ibuprofen, he added.
WASHINGTON (AP) Americans can order morefree COVID-19 testsonline for home delivery.
The U.S. government is offering to send another round of four at-home virus tests ahead of the typical surge in cases during the winter holiday season.
Anyone who did not order a batch of four COVID-19 tests in September can secure up to eight of them this time around starting Monday atCOVIDtests.gov. The U.S. Postal Service will deliver them for free.
The government is mailing out the coronavirus tests as thethe flu seasonkicks off and a spike inRSV caseshas been reported in some spots around the country. Hospitalizations for COVID-19, which haskilled more than 1 million peoplein the United States, were on the rise this fall but have stayed steady in recent weeks. Immunity from previous vaccinations and infections has kept case counts lower compared with other years.
The new release of free COVID-19 nasal swab tests also comes ahead of the first winter since the pandemic started that insurers are no longer required to cover the cost of them. On average, at-home tests now cost $11 out of pocket, according to an analysis by the nonprofit health research firm KFF.
The Food and Drug Administration also approvedupdated COVID-19 vaccinesin September in the hopes of revving up protection for Americans this winter. The shots target an omicron descendant named XBB.1.5, replacing older vaccines that targeted the original coronavirus strain and a much earlier omicron version. Shots are recommended for everyone age 6 months or older, butuptake has been slow.
U.S. taxpayers have spent tens of billions of dollars to develop COVID-19 tests, vaccines and treatments in the three years sincethe pandemic started.
A Texas A&M University survey of US parents finds that 41% already had or would vaccinate their children against COVID-19, 63% against influenza, and 71% against respiratory syncytial virus(RSV) this fall and winter.
The study, published late last week in Vaccine, involved 5,035 parents of children younger than 18 years surveyed on September 27 and 28, 2023.
In total, 40.9% of respondents said they had or would vaccinate their children against COVID-19, while 63.3% said they would do so against flu, and 71.1% said their children would receive the RSV vaccine.
Predictors of intent to vaccinate included concerns about diseases (average marginal effects [AME] for COVID-19, 0.064; AME for flu, 0.060; and AME for RSV 0.048), as well as trust in health institutions (AME for COVID-19, 0.023; AME for flu, 0.010; AME for RSV, 0.028). Parents who had previously vaccinated their children were also more likely to pursue vaccination (AME for COVID-19, 0.176; AME for flu, 0.438; and AME for COVID-19, 0.194).
Relative to men, women were less likely to say they would vaccinate their children against COVID-19 and flu (AME for COVID-19, 0.076; AME for flu, 0.047). Respondents who indicated that vaccines were important were more likely to pursue vaccination for COVID-19 and RSV (AME, 0.097 and 0.072, respectively).
Worries about a link between vaccination and autismwhich studies have disprovenwere statistically significant for only COVID-19 (AME, -0.030). Relative to political conservatives, liberals were more likely to vaccinate against COVID-19 (AME, 0.076).
The large number of unvaccinated children will likely lead to large numbers of excessive disease in children.
Compared with Democrats, Republications were less inclined to vaccinate their children against COVID-19 (AME, -0.060), and Democrats had higher odds of seeking RSV vaccination (AME, 0.151). The most common reasons for vaccine hesitancy were doubts about safety and the need for vaccination and a lack of information.
"The large number of unvaccinated children will likely lead to large numbers of excessive disease in children," the authors wrote.
A new minimally invasive procedure may restore COVID-related impaired sense of smell, suggests a small study to be presented at next week's Radiological Society of North America (RSNA) annual meeting in Chicago.
Researchers at Jefferson Health in Philadelphia performed computed tomography (CT)-guided stellate ganglion block (SGB) in 54 patients who had long-term parosmia (impaired sense of smell that can lead to a distaste for once-like foods and drinks). The average patient age was 46 years, and 74% were women.
The stellate ganglia, part of the autonomic nervous system, are nerves located on the sides of the neck that deliver signals to the head, neck, arms, and parts of the upper chest.
SGB takes less than 10 minutes and doesn't require sedation or intravenous pain management. The procedure has been used with different degrees of success to treat conditions such as cluster headaches, phantom limb pain, Raynaud's and Meniere's syndromes, chest pain, and abnormal heart rhythms.
"While promising treatments for anosmia [loss of smell] have evolved, parosmia is often refractory [not responsive] to pharmaceutical and topical therapies, leading to mood disorders, weight loss, and decreased quality of life," the researchers wrote, adding that up to 60% of COVID-19 survivors have parosmia for months or years after infection.
Parosmia, in turn, can lead to phantosmia, a condition in which patients detect pleasant or unpleasant smells that aren't there, they said.
An ear, nose, and throat (ENT) olfactory subspecialist referred patients to the study who had COVID-related parosmia for at least 6 months that didn't respond to medications. Using CT guidance, the researchers injected a local anesthetic and an anti-inflammatory drug into the stellate ganglia on the side of the neck, depending on whether the patient was right- or left-handed.
The patients were later surveyed about their olfactory symptoms. Of the 37 patients (65%) for whom follow-up was obtained, 22 (59%) said their sense of smell had improved by 1 week after SGB.
Eighteen of 22 patients (82%) reported progressive improvement and a significant increase in average reported improvement at 1 month. By 3 months, patients with symptom relief reported an average of 49% improvement (range, 10% to 100%).
SGB shows promise for patients with long term post-COVID parosmia, and CT provides ideal efficiency and guidance.
Twenty-six participants returned for an injection on the opposite side of the neck at least 6 weeks after the initial procedure. Among them, all 8 participants who didn't report symptom relief after the first injection said their sense of smell improved at least somewhat after the second procedure, and 12 of 14 (86%) who reported some symptom relief after the first injection reported greater improvement.
Overall, 76 of 80 patients (95%) were diagnosed as having Horner's syndrome, or a disrupted nerve pathway in one side of the brain affecting the eye and face. The syndrome resolved in all affected patients within 30 minutes after SGB. There were no reports of complications or adverse events.
"SGB shows promise for patients with long term post-COVID parosmia, and CT provides ideal efficiency and guidance," the authors wrote. "For patients with improvement post SGB, and [sic] 2nd contralateral treatment may provide additional benefit."
In an RSNA news release, lead author Adam Zoga, MD, MBA, said that the team was impressed with the success of SGB in these patients. "Other treatments have failed to date," he said. "This injection is working."
The Health and Disability Commissioner has found a former Christchurch GP issued more than 280 COVID-19 vaccine exemptions for supposed medical conditions that in some cases didn't exist.
Dr Jonie Girouard was first exposed during a Newshub investigation back in 2021.
Now, a new investigation has found she also misrepresented the COVID-19 vaccine to paying patients.
This is what Newshub caught on camera during the height of the pandemic - Dr Jonie Girouard holding court in her Christchurch clinic.
"You're here because you're not crazy about being vaccinated? Right, well you're in the right spot!" she was filmed saying.
On offer? $80 exemptions, which weren't legally binding, supposedly issued on medical grounds.
"Instead, what we're trying to do is give a medical certificate saying that you've been assessed and it's not appropriate for you to receive the current vaccine," she said on camera.
Back in 2021, our hidden camera revealed how easy it was - a few questions, and minimal tests.
The commissioner's report reveals Dr Girouard issued 282 medical certificates to patients regarding the COVID-19 vaccine.
The problem? They stated the vaccine was unsuitable for the holder based on medical conditions when there were no medical conditions.
Dr Girouard was also meant to be vaccinated to see patients - but she wasn't.
The report reveals more. Dr Girouard failed to provide evidence-based information about the vaccine to patients.
"I mean, really, this is horrible, horrible medicine," she was filmed saying.
Dr Girouard is deregistered and left New Zealand. The Health and Disability Commissioner says her competence should be reviewed if she ever returns here to practice.
SPRINGFIELD, Mass. (WWLP) An additional $2 million has been allocated to help Springfield residents who were impacted by the COVID-19 pandemic.
Of approximately 19,000 applications, over 7,100 households have been approved for assistance. Due to the high demand, Mayor Domenic Sarno has added an additional $2 million from the American Rescue Plan Act funds to the citys direct assistance for households account.
Applications for the ARPA Household Direct Assistance Program closed onJanuary 15th. Those who were approved were sent an eligibility letter from Public Partnership, LLC followed by a Money Network Debit Card within 7-10 business days.
A total of $12 million has been allocated to help Springfield residents who were disproportionately impacted by the COVID-19 pandemic. Those eligible had to provide proof of residency and show documentation that the household was receiving some form of programed assistance, such as Supplemental Nutrition Assistance Program (SNAP), Special Supplemental Nutrition Program for Women, Infants and Children (WIC), unemployment benefits, etc.
Public Partnership, LLC reviewed all applications and noted that over 1,000 applications have been flagged as either fraudulent or duplicate requests.
Mayor Sarno states, Originally my administration had allocated $10 million into our Direct Assistance for Household applications, however, due to the high volume of completed and eligible applications, I am allocating an additional $2 million to process and award as many eligible household applications that meet the award and federal criteria as possible. This now brings the total amount allocated into our Direct Household Assistance to $12 million. I want to thank everyone for their continued patience, as we continue to have our third party, Public Partnership, LLC (PPL) carefully review and process all of the applications received. To guard against potential fraud, which we have already flagged over 1,000 applications that do not meet the federal requirements, we have asked PPL to thoroughly review all applications and submitted materials to ensure they meet the eligibility criteria and to make sure that only our Springfield residents that meet the requirements are approved.
WWLP-22News, an NBC affiliate, began broadcasting in March 1953 providing local news, network, syndicated, and local programming to western Massachusetts. Follow 22News on Facebook, Twitter, and Instagram.
Schneider, I. E. et al. COVID-19 compliance among urban trail users: Behavioral insights and environmental implications. J. Outdoor Recreat. Tour. 77, 100396. https://doi.org/10.1016/j.jort.2021.100396 (2021).
Article Google Scholar
Schgner, J. P. et al. Monitoring recreation across European nature areas: A geo-database of visitor counts, a review of literature and a call for a visitor counting reporting standard. J. Outdoor Recreat. Tour. 18, 4455 (2017).
Article Google Scholar
Ghermandi, A. & Sinclair, M. Passive crowdsourcing of social media in environmental research: A systematic map. Glob. Environ. Change 55, 3647 (2019).
Article Google Scholar
Falk, M. T. & Hagsten, E. Visitor flows to World Heritage Sites in the era of Instagram. J. Sustain. Tour. 29, 15471564 (2021).
Article Google Scholar
Sinclair, M., Mayer, M., Woltering, M. & Ghermandi, A. Using social media to estimate visitor provenance and patterns of recreation in Germanys national parks. J. Environ. Manage. 263, 110418 (2020).
Article PubMed Google Scholar
Tenkanen, H. et al. Instagram, Flickr, or Twitter: Assessing the usability of social media data for visitor monitoring in protected areas. Sci. Rep. 7, 17615 (2017).
Article ADS PubMed PubMed Central Google Scholar
Li, J., Xu, L., Tang, L., Wang, S. & Li, L. Big data in tourism research: A literature review. Tour. Manag. 68, 301323 (2018).
Article Google Scholar
Guan, C. et al. Seasonal variations of park visitor volume and park service area in Tokyo: A mixed-method approach combining big data and field observations. Urban For. Urban Green. 58, 126973 (2021).
Article Google Scholar
Hara, Y. & Yamaguchi, H. Japanese travel behavior trends and change under COVID-19 state-of-emergency declaration: Nationwide observation by mobile phone location data. Transp. Res. Interdiscip. Perspect. 9, 100288 (2021).
PubMed Google Scholar
Jaung, W. & Carrasco, L. R. Using mobile phone data to examine weather impacts on recreational ecosystem services in an urban protected area. Sci. Rep. 11, 5544 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Kubo, T. et al. Mobile phone network data reveal nationwide economic value of coastal tourism under climate change. Tour. Manag. 77, 104010 (2020).
Article Google Scholar
Creany, N. E. et al. Estimating trail use and visitor spatial distribution using mobile device data: An example from the Nature Reserve of Orange County, California USA. Environ. Chall. 4, 100171. https://doi.org/10.1016/j.envc.2021.100171 (2021).
Article Google Scholar
Geng, D., Innes, J., Wu, W. & Wang, G. Impacts of COVID-19 pandemic on urban park visitation: A global analysis. J. For. Res. 32, 553567 (2021).
Article CAS Google Scholar
Rice, W. L. & Pan, B. Understanding changes in park visitation during the COVID-19 pandemic: A spatial application of big data. Wellbeing Space Soc. 2, 100037 (2021).
Article PubMed PubMed Central Google Scholar
Dai, P., Zhang, S., Gong, Y., Zhou, Y. & Hou, H. A crowd-sourced valuation of recreational ecosystem services using mobile signal data applied to a restored wetland in China. Ecol. Econ. 192, 107249 (2022).
Article Google Scholar
Byczek, C., Longaretti, P.-Y., Renaud, J. & Lavorel, S. Benefits of crowd-sourced GPS information for modelling the recreation ecosystem service. PLOS ONE 13, e0202645 (2018).
Article PubMed PubMed Central Google Scholar
Schirpke, U. et al. Emerging technologies for assessing ecosystem services: A synthesis of opportunities and challenges. Ecosyst. Serv. 63, 101558 (2023).
Article Google Scholar
Martinez-Harms, M. J. et al. Inequality in access to cultural ecosystem services from protected areas in the Chilean biodiversity hotspot. Sci. Total Environ. 636, 11281138 (2018).
Article ADS CAS PubMed Google Scholar
Kim, H., Shoji, Y., Mameno, K., Kubo, T. & Aikoh, T. Changes in visits to green spaces due to the COVID-19 pandemic: Focusing on the proportion of repeat visitors and the distances between green spaces and visitors places of residences. Urban For. Urban Green. 80, 127828 (2023).
Article PubMed PubMed Central Google Scholar
Smith, M. K. S. et al. Sustainability of protected areas: Vulnerabilities and opportunities as revealed by COVID-19 in a national park management agency. Biol. Conserv. 255, 108985 (2021).
Article Google Scholar
Bratman, G. N. et al. Nature and mental health: An ecosystem service perspective. Sci. Adv. 5, eaax0903 (2019).
Article ADS PubMed PubMed Central Google Scholar
Mameno, K., Kubo, T., Oguma, H., Amagai, Y. & Shoji, Y. Decline in the alpine landscape aesthetic value in a national park under climate change. Clim. Change 170, 35 (2022).
Article ADS Google Scholar
Oteros-Rozas, E., Martn-Lpez, B., Fagerholm, N., Bieling, C. & Plieninger, T. Using social media photos to explore the relation between cultural ecosystem services and landscape features across five European sites. Ecol. Indic. 94, 7486 (2018).
Article Google Scholar
Vallet, A. et al. Relationships between ecosystem services: Comparing methods for assessing tradeoffs and synergies. Ecol. Econ. 150, 96106 (2018).
Article Google Scholar
Archetti, M., Richardson, A. D., OKeefe, J. & Delpierre, N. Predicting climate change impacts on the amount and duration of autumn colors in a New England forest. PLoS ONE 8, e57373 (2013).
Article ADS CAS PubMed PubMed Central Google Scholar
Diffenbaugh, N. S. et al. The COVID-19 lockdowns: A window into the Earth System. Nat. Rev. Earth Environ. 1, 470481 (2020).
Article ADS CAS Google Scholar
Derks, J., Giessen, L. & Winkel, G. COVID-19-induced visitor boom reveals the importance of forests as critical infrastructure. For. Policy Econ. 118, 102253 (2020).
Article PubMed PubMed Central Google Scholar
Rice, W. L. et al. Changes in recreational behaviors of outdoor enthusiasts during the COVID-19 pandemic: Analysis across urban and rural communities. J. Urban Ecol. 6, juaa020 (2020).
Article Google Scholar
Souza, C. N. et al. No visit, no interest: How COVID-19 has affected public interest in worlds national parks. Biol. Conserv. 256, 109015 (2021).
Article Google Scholar
Annerstedt, M. et al. Green qualities in the neighbourhood and mental healthResults from a longitudinal cohort study in Southern Sweden. BMC Public Health 12, 337 (2012).
Article PubMed PubMed Central Google Scholar
Jones, N. et al. COVID-19 and protected areas: Impacts, conflicts, and possible management solutions. Conserv. Lett. 14, e12800 (2021).
Article PubMed PubMed Central Google Scholar
Bowler, D. E., Buyung-Ali, L. M., Knight, T. M. & Pullin, A. S. A systematic review of evidence for the added benefits to health of exposure to natural environments. BMC Public Health 10, 456 (2010).
Article PubMed PubMed Central Google Scholar
Miller-Rushing, A. J. et al. COVID-19 pandemic impacts on conservation research, management, and public engagement in US national parks. Biol. Conserv. 257, 109038 (2021).
Article PubMed PubMed Central Google Scholar
Nicola, M. et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. Lond. Engl. 78, 185193 (2020).
Article Google Scholar
Akhmetzhanov, A. R. et al. Estimation of the actual incidence of coronavirus disease (COVID-19) in emergent hotspots: The example of Hokkaido, Japan during FebruaryMarch 2020. J. Clin. Med. 10, 2392 (2021).
Article CAS PubMed PubMed Central Google Scholar
Anzai, A. & Nishiura, H. Go To Travel campaign and travel-associated coronavirus disease 2019 cases: A descriptive analysis, JulyAugust 2020. J. Clin. Med. 10, 398 (2021).
Article CAS PubMed PubMed Central Google Scholar
Chiesura, A. The role of urban parks for the sustainable city. Landsc. Urban Plan. 68, 129138 (2004).
Article Google Scholar
Amoako-Tuffour, J. & Martnez-Espieira, R. Leisure and the net opportunity cost of travel time in recreation demand analysis: An application to Gros Morne National Park. J. Appl. Econ. 15, 2549 (2012).
Article Google Scholar
Guo, S. et al. Analysis of factors affecting urban park service area in Beijing: Perspectives from multi-source geographic data. Landsc. Urban Plan. 181, 103117 (2019).
Article ADS Google Scholar
Kim, J. Y., Koide, D., Ishihama, F., Kadoya, T. & Nishihiro, J. Current site planning of medium to large solar power systems accelerates the loss of the remaining semi-natural and agricultural habitats. Sci. Total Environ. 779, 146475 (2021).
Article ADS CAS PubMed Google Scholar
Wintle, B. A. et al. Global synthesis of conservation studies reveals the importance of small habitat patches for biodiversity. Proc. Natl. Acad. Sci. 116, 909914 (2019).
Article ADS CAS PubMed Google Scholar
Cant-Salazar, L. & Gaston, K. J. Very large protected areas and their contribution to terrestrial biological conservation. BioScience 60, 808818 (2010).
Article Google Scholar
Hadwen, W. L., Hill, W. & Pickering, C. M. Icons under threat: Why monitoring visitors and their ecological impacts in protected areas matters. Ecol. Manag. Restor. 8, 177181 (2007).
Article Google Scholar
Walden-Schreiner, C., Rossi, S. D., Barros, A., Pickering, C. & Leung, Y.-F. Using crowd-sourced photos to assess seasonal patterns of visitor use in mountain-protected areas. Ambio 47, 781793 (2018).
Article PubMed PubMed Central Google Scholar
Worboys, G. L., Lockwood, M., Kothari, A., Feary, S. & Pulsford, I. Protected Area Governance and Management (ANU Press, 2015).
Book Google Scholar
Yabe, T. et al. Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic. Sci. Rep. 10, 18053 (2020).
Article CAS PubMed PubMed Central Google Scholar
Fasiolo, M. et al. Package mgcViz. Visualisations for generalised additive models. Package mgcViz. Visualisations for generalised additive models (2021).
Wood, S. & Wood, M. S. Package mgcv (v 1.8-42). Package mgcv (v 1.8-42) (2022).
app.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.
Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on app.com
